日本ケミファ(株)の貸借残高情報
| 主市場 | 業種 | 証券コード/EDINET | 英名称 |
|---|---|---|---|
| 東証STD | 医薬品 | 4539/E00957 | NIPPON CHEMIPHAR CO., LTD. |
| 公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
|---|---|---|---|---|---|---|---|---|---|
| 2024/09/27 | 日証協 | 38,552株 | -72.39% | 300株 | +29.31% | 68,361株 | -1.88% | 19,272株 | +1381.32% |
| 2024/09/20 | 日証協 | 139,652株 | +0.17% | 232株 | -97.36% | 69,668株 | -2.79% | 1,301株 | 0% |
| 2024/09/13 | 日証協 | 139,420株 | -0.78% | 8,804株 | -2.95% | 71,668株 | 0% | 0株 | -100% |
| 2024/09/06 | 日証協 | 140,520株 | -1.29% | 9,072株 | -48.48% | 71,668株 | -1.38% | 2,000株 | -35.48% |
| 2024/08/30 | 日証協 | 142,352株 | +0.21% | 17,608株 | -34.33% | 72,668株 | +4.01% | 3,100株 | +55% |
| 2024/08/23 | 日証協 | 142,052株 | +0.56% | 26,812株 | +1014.38% | 69,868株 | -1.55% | 2,000株 | +25% |
| 2024/08/16 | 日証協 | 141,255株 | -0.21% | 2,406株 | -86.49% | 70,968株 | +0.14% | 1,600株 | -44.83% |
| 2024/08/09 | 日証協 | 141,552株 | +1.29% | 17,808株 | +5895.96% | 70,868株 | +0.71% | 2,900株 | +93.08% |
| 2024/08/02 | 日証協 | 139,755株 | -1.96% | 297株 | -67.11% | 70,368株 | -1.54% | 1,502株 | -57.09% |
| 2024/07/26 | 日証協 | 142,555株 | -2.2% | 903株 | -95.25% | 71,466株 | -2.72% | 3,500株 | +24.96% |
| 2024/07/19 | 日証協 | 145,755株 | -0.27% | 19,008株 | 0% | 73,465株 | +9.38% | 2,801株 | -58.82% |
| 2024/07/12 | 日証協 | 146,155株 | +0.07% | 19,008株 | -1.55% | 67,163株 | +5% | 6,802株 | +172.08% |
| 2024/07/05 | 日証協 | 146,055株 | +0.21% | 19,308株 | +109.78% | 63,963株 | -0.15% | 2,500株 | +2375.25% |
| 2024/06/28 | 日証協 | 145,755株 | -0.82% | 9,204株 | +9104% | 64,062株 | -2.92% | 101株 | -74.81% |
| 2024/06/21 | 日証協 | 146,955株 | -1.41% | 100株 | -99.05% | 65,987株 | -3.79% | 401株 | -42.8% |
| 2024/06/14 | 日証協 | 149,056株 | -0.33% | 10,501株 | 0% | 68,587株 | +0.15% | 701株 | -46.08% |
| 2024/06/07 | 日証協 | 149,556株 | -0.47% | 0株 | 0% | 68,487株 | -0.29% | 1,300株 | +116.31% |
| 2024/05/31 | 日証協 | 150,256株 | -0.6% | 0株 | -100% | 68,686株 | -0.72% | 601株 | -59.96% |
| 2024/05/24 | 日証協 | 151,156株 | -0.13% | 603株 | -59.88% | 69,186株 | +0.44% | 1,501株 | -16.61% |
※株式分割は考慮していませんのでご注意ください。